Lantheus Holdings, Inc. Profile Avatar - Palmy Investing

Lantheus Holdings, Inc.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound en…

Drug Manufacturers - Specialty & Generic
US, North Billerica [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Lantheus Holdings, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of LNTH's Analysis
CIK: 1521036 CUSIP: 516544103 ISIN: US5165441032 LEI: - UEI: -
Secondary Listings
LNTH has no secondary listings inside our databases.